WORK Operating Cycle from 2010 to 2026

WOK Stock   1.92  0.14  7.87%   
WORK Medical Operating Cycle yearly trend continues to be quite stable with very little volatility. The value of Operating Cycle is projected to decrease to 198.57. From the period between 2010 and 2026, WORK Medical, Operating Cycle regression line of its data series had standard deviation of  106.21 and standard deviation of  106.21. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
285.36
Current Value
198.57
Quarterly Volatility
106.21101682
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check WORK Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among WORK Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.2 M, Interest Expense of 410.4 K or Selling General Administrative of 3.2 M, as well as many indicators such as Price To Sales Ratio of 545, Dividend Yield of 0.0 or PTB Ratio of 691. WORK financial statements analysis is a perfect complement when working with WORK Medical Valuation or Volatility modules.
  
Build AI portfolio with WORK Stock
Check out the analysis of WORK Medical Correlation against competitors.

Latest WORK Medical's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of WORK Medical Technology over the last few years. It is WORK Medical's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in WORK Medical's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

WORK Operating Cycle Regression Statistics

Arithmetic Mean182.34
Geometric Mean161.27
Coefficient Of Variation58.25
Mean Deviation84.29
Median117.53
Standard Deviation106.21
Sample Variance11,281
Range361
R-Value0.67
Mean Square Error6,649
R-Squared0.45
Significance0
Slope14.07
Total Sum of Squares180,492

WORK Operating Cycle History

2026 198.57
2025 285.36
2023 317.07
2022 474.54
2021 217.88
2020 114.03

About WORK Medical Financial Statements

WORK Medical investors utilize fundamental indicators, such as Operating Cycle, to predict how WORK Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 285.36  198.57 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether WORK Medical Technology is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if WORK Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Work Medical Technology Stock. Highlighted below are key reports to facilitate an investment decision about Work Medical Technology Stock:
Check out the analysis of WORK Medical Correlation against competitors.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of WORK Medical. Anticipated expansion of WORK directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive WORK Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.95)
Earnings Share
-2.8 K
Revenue Per Share
78.11
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.09)
Investors evaluate WORK Medical Technology using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating WORK Medical's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause WORK Medical's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between WORK Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if WORK Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, WORK Medical's market price signifies the transaction level at which participants voluntarily complete trades.